Cited by 234Radiation Dose and ImagingThyroid Cancer Diagnosis and TreatmentRadiopharmaceutical Chemistry and Applications

Radiation Safety in the Treatment of Patients with Thyroid Diseases by Radioiodine 131 I: Practice Recommendations of the American Thyroid Association

Open access
Sisson, The American Thyroid Association Ta, Freitas, John, McDougall, Iain Ross, Dauer, Lawrence T., Hurley, James R., Brierley, James D., Edinboro, Charlotte H., Rosenthal, David +6 more·2011·Thyroid

Abstract

BACKGROUND: Radiation safety is an essential component in the treatment of patients with thyroid diseases by ¹³¹I. The American Thyroid Association created a task force to develop recommendations that would inform medical professionals about attainment of radiation safety for patients, family members, and the public. The task force was constituted so as to obtain advice, experience, and methods from relevant medical specialties and disciplines. METHODS: Reviews of Nuclear Regulatory Commission regulations and International Commission on Radiological Protection [corrected] recommendations formed the basic structure of the recommendations. Members of the task force contributed both ideas and methods that are used at their respective institutions to aid groups responsible for treatments and that instruct patients and caregivers in the attainment of radiation safety. There are insufficient data on long-term outcomes to create evidence-based guidelines. RESULTS: The information was used to compile delineations of radiation safety. Factors and situations that govern implementation of safety practices are cited and discussed. Examples of the development of tables to ascertain the number of hours or days (24-hour cycles) of radiation precaution appropriate for individual patients treated with ¹³¹I for hyperthyroidism and thyroid cancer have been provided. Reminders in the form of a checklist are presented to assist in assessing patients while taking into account individual circumstances that would bear on radiation safety. Information is presented to supplement the treating physician's advice to patients and caregivers on precautions to be adopted within and outside the home. CONCLUSION: Recommendations, complying with Nuclear Regulatory Commission regulations and consistent with guidelines promulgated by the National Council on Radiation Protection and Measurement (NCRP-155), can help physicians and patients maintain radiation safety after treatment with ¹³¹I of patients with thyroid diseases. Both treating physicians and patients must be informed if radiation safety, an integral part of therapy with ¹³¹I, is to be attained. Based on current regulations and understanding of radiation exposures, recommendations have been made to guide physicians and patients in safe practices after treatment with radioactive iodine.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1089/thy.2010.0403

Cites

30 of 31 references verified0 citation errors · 1 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • In the United States, the treating physician must ensure and document that no adult member of the public is exposed to 0.5 mSv when the patient is discharged with a retained activity of 33 mCi or greater, or emits at least 7 mrem/h at 1 m.

    “In the United States, the treating physician must ensure and document that no adult member of the public is exposed to 0.5 mSv (500 milli-roentgen equivalent in man [mrem]) when the patient is discharged with a retained activity of 33 mCi (1.22 GBq) or greater, or emits ‡7 mrem/h (70 lSv/h) at 1 m.”

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Sisson, T. A. T. A. T., Freitas, J., McDougall, I. R., Dauer, L. T., Hurley, J. R., Brierley, J. D., Edinboro, C. H., Rosenthal, D., Thomas, M. J., Wexler, J. A., Asamoah, E., Avram, A. M., Milas, M., & Greenlee, C.
Affiliations
  • Division of Nuclear Medicine, Department of Radiology, University of Michigan Health System, Ann Arbor, Michigan.
  • Trinity Health Ann Arbor Hospital (US)
  • Memorial Sloan Kettering Cancer Center (US)
  • University of Toronto (CA)
  • Exponent (United States) (US)
  • Nassau University Medical Center (US)
  • MedStar Washington Hospital Center (US)
  • Michigan Medicine (US)
  • Cleveland Clinic (US)
  • Western Slope Endocrinology, Grand Junction, Colorado.
Venue
Thyroid
Published
2011-04
Volume
21
Issue
4
Pages
335-346
ISSN
  • 1050-7256 (ISSN-L)
  • 1557-9077
OpenAlex
W1980665887
Cited by
234
References
30
Citations by year
2026: 16 · 2025: 17 · 2024: 13 · 2023: 9 · 2022: 16 · 2021: 14 · 2020: 14 · 2019: 12 · 2018: 17 · 2017: 19 · 2016: 19 · 2015: 21 · 2014: 14 · 2013: 12 · 2012: 15
FWCI
11.26
Type
journal article
Language
en
Open access
Locations
  • Thyroid (publishedVersion)
  • PubMed (publishedVersion)
  • Deep Blue (University of Michigan) (submittedVersion)
Funders
Strong
Topics
  • Health Sciences › Medicine › Radiology, Nuclear Medicine and Imaging › Radiation Dose and Imaging
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Thyroid Cancer Diagnosis and Treatment
  • Health Sciences › Medicine › Radiology, Nuclear Medicine and Imaging › Radiopharmaceutical Chemistry and Applications
Keywords
radiation protection, iodine-131, radioiodine therapy, thyroid dysfunction, hyperthyroidism, thyroid cancer, patient and caregiver education, radiation dose limits, radiation protection guidelines
MeSH terms
Breast Feeding, Family, Female, Government Agencies, Humans, Hyperthyroidism, Iodine Radioisotopes, Pregnancy, Radiation Protection, Safety, Societies, Medical, Thyroid Diseases, Thyroid Neoplasms, United States

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review